Snake venom toxin (SVT) from Vipera lebetina turanica contains a mixture of different
enzymes and
proteins.
Peroxiredoxin 6 (PRDX6) is known to be a stimulator of
lung cancer cell growth. PRDX6 is a member of
peroxidases, and has
calcium-independent phospholipase A2 (iPLA2) activities. PRDX6 has an
AP-1 binding site in its promoter region of the gene. Since
AP-1 is implicated in
tumor growth and PRDX6 expression, in the present study, we investigated whether SVT inhibits PRDX6, thereby preventing human
lung cancer cell growth (A549 and NCI-H460) through inactivation of
AP-1. A docking model study and pull down assay showed that SVT completely fits on the basic leucine zipper (bZIP) region of c-Fos of
AP-1. SVT (0-10 μg/ml) inhibited
lung cancer cell growth in a concentration dependent manner through induction of apoptotic cell death accompanied by induction of cleaved
caspase-3, -8, -9, Bax, p21 and p53, but decreased cIAP and Bcl2 expression via inactivation of
AP-1. In an xenograft in vivo model, SVT (0.5 mg/kg and 1 mg/kg) also inhibited
tumor growth accompanied with the reduction of PRDX6 expression, but increased expression of proapoptotic
proteins. These data indicate that SVT inhibits
tumor growth via inhibition of PRDX6 activity through interaction with its
transcription factor AP-1.